[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fxxsi0VwNSqst46a8kHvXVsryrh6VWUEkLuycLa5bm6o":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":35,"phaseBuckets":41,"rows":48},"Smith & Nephew, Inc.",[4],131,false,21,0,17692,1,127,[14,17,20,23,25,28,30,32],{"name":15,"count":16},"Osteoarthritis",12,{"name":18,"count":19},"Rheumatoid Arthritis",8,{"name":21,"count":22},"Knee",6,{"name":24,"count":22},"Pressure Ulcer",{"name":26,"count":27},"Arthroplasty",5,{"name":29,"count":27},"Replacement",{"name":31,"count":27},"Wounds and Injuries",{"name":33,"count":34},"Total Knee Arthroplasty",4,[36],{"nctId":37,"briefTitle":38,"date":39,"intervention":40},"NCT05915078","Evaluation of Outcomes Following In-office Tympanostomy Using the Tula® System: a Prospective, Multi-center Registry","2025-03-30","Iontophoresis and tube placement",[42,43,44,45,46,47],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[49,74,120],{"intervention":40,"totalTrials":11,"cells":50},{"EARLY_PHASE1":51,"PHASE1":53,"PHASE2":55,"PHASE3":57,"PHASE4":59,"NA":61},{"trials":52,"activeCount":9},[],{"trials":54,"activeCount":9},[],{"trials":56,"activeCount":9},[],{"trials":58,"activeCount":9},[],{"trials":60,"activeCount":9},[],{"trials":62,"activeCount":11,"soonestReadout":39},[63],{"nctId":37,"briefTitle":38,"status":64,"phases":65,"primaryCompletion":39,"completion":66,"start":67,"enrollment":68,"conditions":69,"interventions":73},"RECRUITING",[],"2027-06-30","2023-06-15",200,[70,71,72],"Otitis Media With Effusion","Acute Otitis Media","Otitis Media",[40],{"intervention":75,"totalTrials":76,"cells":77},"Santyl",3,{"EARLY_PHASE1":78,"PHASE1":80,"PHASE2":82,"PHASE3":84,"PHASE4":86,"NA":118},{"trials":79,"activeCount":9},[],{"trials":81,"activeCount":9},[],{"trials":83,"activeCount":9},[],{"trials":85,"activeCount":9},[],{"trials":87,"activeCount":9},[88,98,107],{"nctId":89,"briefTitle":90,"status":91,"phases":92,"primaryCompletion":93,"completion":93,"start":94,"enrollment":9,"conditions":95,"interventions":97},"NCT02716519","Use of Santyl Within an Accountable Care Organization","WITHDRAWN",[46],"2018-12","2016-08",[24,96],"Foot Ulcer, Diabetic",[75],{"nctId":99,"briefTitle":100,"status":101,"phases":102,"primaryCompletion":103,"completion":103,"start":94,"enrollment":76,"conditions":104,"interventions":105},"NCT02718625","Study of SANTYL® vs Hydrogel (SoloSite®) for Pressure Ulcers","TERMINATED",[46],"2017-03-09",[24],[75,106],"SoloSite®",{"nctId":108,"briefTitle":109,"status":110,"phases":111,"primaryCompletion":112,"completion":112,"start":113,"enrollment":114,"conditions":115,"interventions":117},"NCT02581488","Use of Santyl in Diabetic Foot Ulcers","COMPLETED",[46],"2017-01-12","2015-10",102,[116,96],"Diabetic Foot",[75],{"trials":119,"activeCount":9},[],{"intervention":106,"totalTrials":11,"cells":121},{"EARLY_PHASE1":122,"PHASE1":124,"PHASE2":126,"PHASE3":128,"PHASE4":130,"NA":136},{"trials":123,"activeCount":9},[],{"trials":125,"activeCount":9},[],{"trials":127,"activeCount":9},[],{"trials":129,"activeCount":9},[],{"trials":131,"activeCount":9},[132],{"nctId":99,"briefTitle":100,"status":101,"phases":133,"primaryCompletion":103,"completion":103,"start":94,"enrollment":76,"conditions":134,"interventions":135},[46],[24],[75,106],{"trials":137,"activeCount":9},[]]